Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 32021D1283

    Commission Implementing Decision (EU) 2021/1283 of 2 August 2021 on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)

    C/2021/5603

    OJ L 279, 3.8.2021, p. 32–34 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    Legal status of the document In force

    ELI: http://data.europa.eu/eli/dec_impl/2021/1283/oj

    3.8.2021   

    EN

    Official Journal of the European Union

    L 279/32

    COMMISSION IMPLEMENTING DECISION (EU) 2021/1283

    of 2 August 2021

    on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

    (Text with EEA relevance)

    THE EUROPEAN COMMISSION,

    Having regard to the Treaty on the Functioning of the European Union,

    Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular the third subparagraph of Article 89(1) thereof,

    Whereas:

    (1)

    Commission Delegated Regulation (EU) No 1062/2014 (2) establishes in its Annex II a list of active substance/product-type combinations included in the review programme of existing active substances in biocidal products on 30 March 2019.

    (2)

    For a number of active substance/product-type combinations included in that list, all the participants have withdrawn or are considered to have withdrawn their support in a timely manner.

    (3)

    In accordance with Article 14(1) of Delegated Regulation (EU) No 1062/2014, the European Chemicals Agency (‘the Agency’) published an open invitation to take over the role of participant for those active substance/product-type combinations for which the role of participant had not previously been taken over. For some of those combinations no notification has been submitted or the notification has been rejected pursuant to Article 17(4) or (5) of that Regulation. Those active substance/product-type combinations which, in accordance with Article 20, first paragraph, point (b), of Delegated Regulation (EU) No 1062/2014, should not be approved for use in biocidal products are the following: metam-sodium (product-types 9 and 11); thiram (product-type 9); bronopol (product-type 9); peroxyoctanoic acid (product-type 2, 3, 4); Malt, ext. – Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Hordeum, Gramineae (product-type 19); 2,2-Dibromo-2-cyanoacetamide (product-type 13).

    (4)

    In addition, in accordance with Article 12(3) of Delegated Regulation (EU) No 1062/2014, the Agency informed the Commission of those active substance/product-type combinations for which all participants have withdrawn or are considered to have withdrawn their support in a timely manner, and for which the role of participant had previously been taken over. Those active substance/product-type combinations which, in accordance with Article 20, first paragraph, point (a), of that Regulation, should not be approved for use in biocidal products are the following: silver, as a nanomaterial (product-types 2, 4, 9); Eucalyptus citriodora oil and citronellal, hydrated, cyclized (product-type 19); 2-Hydroxy-α,α,4-trimethylcyclohexanemethanol (product-type 19); chlorine dioxide generated from sodium chlorite and sodium persulfate (product-types 2, 3, 4, 5, 11); amines, C10-16-alkyldimethyl, N-oxides (product-type 4); Capsicum oleoresin (product-type 19); Capsicum annuum, ext. (product-type 19); reaction mass of (6E)-N-(4-hydroxy-3-methoxy-2-methylphenyl)-8-methylnon-6-enamide and N-(4-hydroxy-3-methoxy-2-methylphenyl)-8- methylnonanamide (product-type 19).

    (5)

    The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Biocidal Products,

    HAS ADOPTED THIS DECISION:

    Article 1

    The active substances listed in the Annex are not approved for the product-types indicated therein.

    Article 2

    This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

    Done at Brussels, 2 August 2021.

    For the Commission

    The President

    Ursula VON DER LEYEN

    (1)   OJ L 167, 27.6.2012, p. 1.

    (2)  Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 294, 10.10.2014, p. 1).

    ANNEX

    Active substance/product-type combinations not approved:

    Entry Number in Annex II to Regulation (EU) No 1062/2014

    Substance name

    Rapporteur Member State

    EC number

    CAS number

    Product-type(s)

    9

    Bronopol

    ES

    200-143-0

    52-51-7

    9

    206

    Thiram

    BE

    205-286-2

    137-26-8

    9

    210

    Metam-sodium

    BE

    205-293-0

    137-42-8

    9, 11

    1023

    Silver, as a nanomaterial

    SE

    231-131-3

    7440-22-4

    2, 4, 9

    494

    2,2-Dibromo-2-cyanoacetamide (DBNPA)

    DK

    233-539-7

    10222-01-2

    13

    1047

    Eucalyptus citriodora oil and citronellal, hydrated, cyclized

    CZ

    n/a

    n/a

    19

    609

    2-Hydroxy-α,α,4-trimethylcyclohexanemethanol

    CZ

    255-953-7

    42822-86-6

    19

    813

    Peroxyoctanoic acid

    FR

    n/a

    33734-57-5

    2, 3, 4

    1044

    Chlorine dioxide generated from sodium chlorite and sodium persulfate

    DE

    n/a

    n/a

    2, 3, 4, 5, 11

    1064

    Malt, ext. Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Hordeum, Gramineae

    AT

    232-310-9

    8002-48-0

    19

    692

    Amines, C10-16-alkyldimethyl, N-oxides

    PT

    274-687-2

    70592-80-2

    4

    1059

    Capsicum oleoresin

    Extractives and their physically modified derivatives. It is a product which may contain resin acids and their esters, terpenes, and oxidation or polymerization products of these terpenes. (Capsicum frutescens, Solanaceae)

    BE

    Not available

    8023-77-6

    19

    1060

    Capsicum annuum, ext.

    Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Capsicum annuum, Solanaceae.

    BE

    283-403-6

    84625-29-6

    19

    1061

    Reaction mass of (6E)-N-(4-hydroxy-3-methoxy-2-methylphenyl)-8-methylnon-6-enamide and N-(4-hydroxy-3- methoxy-2-methylphenyl)-8- methylnonanamide

    BE

    Not available

    Not available

    19
    Top